Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ODTX stock hub

Odyssey Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ODTXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

774.6M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

ODTX

In the news

Latest news · ODTX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-85.5

P25 -105.6P50 -46.5P75 -3.1

ROIC-48

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ODTX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

130

Groups with data

Currency

USD

Showing 130 of 130 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001882782
Company name	Odyssey Therapeutics, Inc.
Country	United States
Country code	US
Employees	100
Enterprise value	$585.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2026-05-08
Last refreshed	2026-05-10
Market cap	$774.6M
Market cap category	Small-Cap
Price	$16.42
Price currency	USD
Rev Per Employee	29,760x
Sector	Healthcare
Sic	2836
Symbol	ODTX
Website	https://odysseytx.com/

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-19.19%
EV/Sales	196.62x
FCF yield	-16.87%
P/B ratio	3.6x
P/S ratio	260.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-118.2M
Net Income	$-148.6M
Net Income Growth Years	0%
Pretax Margin	-5,026.01%
Profit Per Employee	$-1.5M
ROA	-41.66
ROCE	-64
ROE	-85.5
ROIC	-47.96

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth Years	0
Revenue Growth	-33.45x
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.01
Assets	$269.8M
Cash	$181.4M
Current Assets	$192.5M
Current Liabilities	$22.1M
Debt	$27.1M
Debt Equity	$0.13
Equity	$215.3M
Interest Coverage	-9,159.8
Liabilities	$54.5M
Long Term Assets	$77.3M
Long Term Liabilities	$32.4M
Net Cash	$189.4M
Net Cash By Market Cap	$24.46
Net Debt Equity	$-0.88
Tangible Book Value	$-502.9M
Tangible Book Value Per Share	$-23.17

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.2
Net Working Capital	$-12M
Quick ratio	6.85
Working Capital	$164.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-562.18%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
All Time High	20.3
All Time High Change	-19.11%
All Time High Date	2026-05-08
All Time Low	15.35
All Time Low Change	6.97%
All Time Low Date	2026-05-08
High	20.3
High52	18
High52 Date	2026-05-07
High52ch	-8.78%
Low	15.35
Low52	16.42
Low52 Date	2026-05-07
Low52ch	0%
RSI	0
RSI Monthly	0
RSI Weekly	0
Total Return	-562.18%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-155.7M
Operating margin	-5,232.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	46,175,483%
Float Percent	97.88%
Shares Insiders	2.12%
Shares Institutions	1.09%
Shares Out	47,174,156
Shares Yo Y	562.18%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-145M
Average Volume	0x
Bv Per Share	-22.5
CAPEX	$-1.2M
Change	-8.78%
Change From Open	-17.9
Close	18
Days Gap	11.11
Depreciation Amortization	4,911,000
Dollar Volume	52,073,320.7
EBIT	$-155.7M
EBITDA	$-150.8M
EPS	$-5.16
F Score	1
FCF	$-130.7M
FCF EV Yield	-22.34x
FCF Per Share	$-2.77
Financing CF	215,646,000
Fiscal Year End	December
Founded	2,021
Goodwill	13,554,000
Income Tax	$-927,000
Investing CF	-103,943,000
Iprfo	-17.9
Is Spac	No
Last Report Date	2023-12-31
Last Split Type	Never
Net CF	-17,449,000
Open	20
Position In Range	21.62
Post Close	16.42
Postmarket Change Percent	-2.25
Postmarket Price	$16.05
Ppne	46,733,000
Price Date	2026-05-08
Relative Volume	3.76x
Revenue	2,976,000x
SBC By Revenue	481.25x
Share Based Comp	14,322,000
Tax By Revenue	-31.15x
Us State	MA
Volume	3,171,335
Z Score	-4.11

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ODTX pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns ODTX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+1.1%

Float: +97.9% of shares outstanding

Insider ownership

+2.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+562.2%

Negative means the company is buying back shares.

Technical

ODTX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

0.0

Below 30: short-term oversold

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

n/a

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ODTX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ODTX stock rating?

Odyssey Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ODTX analysis?

The full report lives at /stocks/ODTX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ODTX?

The latest report frames ODTX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ODTX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.